| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.27 | 5e-08 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.25 | 3e-06 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.22 | 3e-05 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.2 | 7e-05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.2 | 9e-05 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.23 | 0.001 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |